HomeECOR • NASDAQ
add
electroCore, Inc.
Previous close
$4.95
Day range
$4.91 - $5.87
Year range
$4.47 - $19.49
Market cap
40.07M USD
Avg Volume
140.36K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Revenue | 6.72M | 23.44% |
Operating expense | 9.53M | 13.37% |
Net income | -3.86M | -9.95% |
Net profit margin | -57.37 | 10.93% |
Earnings per share | — | — |
EBITDA | -3.67M | -0.66% |
Effective tax rate | 1.23% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 7.76M | -1.15% |
Total assets | 16.04M | 15.49% |
Total liabilities | 11.68M | 24.29% |
Total equity | 4.36M | — |
Shares outstanding | 7.42M | — |
Price to book | 8.39 | — |
Return on assets | -52.34% | — |
Return on capital | -94.47% | — |
Cash Flow
Net change in cash
| (USD) | Mar 2025info | Y/Y change |
|---|---|---|
Net income | -3.86M | -9.95% |
Cash from operations | -4.36M | -70.25% |
Cash from investing | 4.50M | — |
Cash from financing | 180.00K | — |
Net change in cash | 327.00K | 113.17% |
Free cash flow | -2.87M | -51.47% |
About
electroCore, Inc. is a medical technology company based in Basking Ridge, New Jersey. electroCore was co-founded in 2005 by JP Errico, Thomas J. Errico, MD, Charles Theofilos, MD, and Peter Staats, MD. The current chief executive officer is Daniel S. Goldberger. electroCore has one product called gammaCore, a non-invasive, commercially available product that uses vagus nerve stimulation. Wikipedia
Founded
2005
Headquarters
Website
Employees
73
